SCHEMBL25760304

SCHEMBL25760304

COc1ccc(Cc2nc3c(Cc4ccccc4)[nH]c(-c4cccc(C)c4)cn-3c2=O)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 7/20 0.44
▸ SMN1; SMN2 Q16637 5/20 0.44
▸ ALDH1A1 P00352 6/20 0.42
▸ MAPT P10636 4/20 0.42
▸ HTT P42858 3/20 0.42
▸ NPSR1 Q6W5P4 3/20 0.42
▸ KMT2A Q03164 3/20 0.42
▸ MEN1 O00255 2/20 0.42
▸ LMNA P02545 2/20 0.42
▸ RAB9A P51151 3/20 0.42
▸ TDP1 Q9NUW8 2/20 0.42
▸ NPC1 O15118 2/20 0.42
▸ HPGD P15428 5/20 0.38
▸ HSD17B10 Q99714 2/20 0.38
▸ ADORA3 P0DMS8 1/20 0.38
▸ APAF1 O14727 1/20 0.38
▸ TP53 P04637 1/20 0.38
▸ POLB P06746 1/20 0.38
▸ PSD A5PKW4 1/20 0.37
▸ GAA P10253 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25760298 0.94 MAPT (0.46) KDM4ESMN1; SMN2ALDH1A1MAPTHTT
SCHEMBL25760294 0.92 RAB9A (0.40) KDM4ESMN1; SMN2ALDH1A1MAPTHTT
SCHEMBL4547065 0.92 ALDH1A1 (0.45) KDM4ESMN1; SMN2ALDH1A1HTTNPSR1
SCHEMBL21751461 0.90 KDM4E (0.41) KDM4ESMN1; SMN2ALDH1A1MAPTHTT
SCHEMBL13484442 0.90 ALDH1A1 (0.42) KDM4ESMN1; SMN2ALDH1A1MAPTHTT
SCHEMBL12735455 0.90 ALDH1A1 (0.43) KDM4ESMN1; SMN2ALDH1A1MAPTHTT
SCHEMBL25760275 0.89 THRB (0.36) KDM4ESMN1; SMN2ALDH1A1MAPTHTT
SCHEMBL25760289 0.89 KMT2A (0.36) SMN1; SMN2ALDH1A1MAPTKMT2AMEN1
SCHEMBL10012889 0.89 KDM4E (0.43) KDM4ESMN1; SMN2ALDH1A1MAPTHTT
SCHEMBL25760166 0.88 THRB (0.38) SMN1; SMN2ALDH1A1MAPTHTTNPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11691976-B2 Coelenterazine analogues PROMEGA CORPORATION (US) 2023-07-04 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11691976-B2 Coelenterazine analogues GLB1, SI, TCF7L2 KDM4E 3302/4885SMN1; SMN2 3970/4885ALDH1A1 3541/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback